ArticleTrials2021

Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.

L Guglielmetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.